Artificial Intelligence-Based Methods for Precision Medicine: Diabetes Risk Prediction

Farida Mohsen,Hamada R. H. Al-Absi,Noha A.Yousri,Nady El Hajj,Zubair Shah

DOI: https://doi.org/10.48550/arXiv.2305.16346

2023-05-24

Abstract:The rising prevalence of type 2 diabetes mellitus (T2DM) necessitates the development of predictive models for T2DM risk assessment. Artificial intelligence (AI) models are being extensively used for this purpose, but a comprehensive review of their advancements and challenges is lacking. This scoping review analyzes existing literature on AI-based models for T2DM risk prediction. Forty studies were included, mainly published in the past four years. Traditional machine learning models were more prevalent than deep learning models. Electronic health records were the most commonly used data source. Unimodal AI models relying on EHR data were prominent, while only a few utilized multimodal models. Both unimodal and multimodal models showed promising performance, with the latter outperforming the former. Internal validation was common, while external validation was limited. Interpretability methods were reported in half of the studies. Few studies reported novel biomarkers, and open-source code availability was limited. This review provides insights into the current state and limitations of AI-based T2DM risk prediction models and highlights challenges for their development and clinical implementation.

Machine Learning,Artificial Intelligence

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop and evaluate artificial intelligence (AI) models for type 2 diabetes mellitus (T2DM) risk prediction. Specifically, the paper aims to comprehensively analyze the current application status of existing AI technologies in T2DM risk prediction, and explore the performance of these models, the types of data used, prediction indicators, and model interpretation methods, etc. In addition, the paper also focuses on the challenges and limitations faced by these AI models in clinical applications, and points out the directions for future research.

### Overview of Main Problems:
1. **Application Status of AI Models**: The paper conducts a comprehensive review of studies using AI technology for T2DM risk prediction, with a focus on analyzing the performance and application of different types of AI models (such as traditional machine - learning models and deep - learning models).
2. **Data Types and Sources**: It explores the roles and effects of different types of data (such as electronic health records, multi - omics data, medical images, etc.) in T2DM risk prediction.
3. **Model Performance Evaluation**: It analyzes the performance indicators of different AI models, such as the area under the receiver operating characteristic curve (AUC), classification indicators, etc., and discusses the calibration and discrimination abilities of the models.
4. **Model Interpretability**: It evaluates the interpretation methods used in different studies to identify and explain important risk factors and biomarkers.
5. **Challenges in Clinical Applications**: It discusses the main challenges faced by AI models in clinical implementation, including data diversity and complexity, model generalization ability, lack of external validation, etc.
6. **Directions for Future Research**: It points out the knowledge gaps in current research and proposes key areas for future research to promote the further application of AI in T2DM risk prediction.

Through these analyses, the paper aims to provide valuable insights for researchers and clinicians, and promote the development of precision medicine and the formulation of T2DM prevention strategies.